MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections

Life Science

Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland

Life Science

China Medical In-Licenses China Rights to VAXIMM’s Immunotherapies

Life Science

WuXi AppTec Files for $1 Billion-Plus IPO in Hong Kong

Life Science

Digital China Health to Promote Genomics Diagnostic Support System in China

Life Science

Warburg Pincus Invests $800M In Chinese Logistics Firm NewEase China

Technology

Tiantu Capital Leads $145M Series B Round In Chinese Home Furnishing Platform Aijia

Technology

AstraZeneca Plans to Seek Regulatory Approval for COPD Drug PT010 Following Phase III Trial

Life Science

Shanghai Introduces Measures To Boost AI Industry Via Talent, Data, Capital

Technology

R&D Cooperation Between China and Western Pharma Companies Up 70 Percent

Life Science

Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation

Life Science

China Renaissance Seeks Up to $377M In Hong Kong IPO

Technology

Shanghai Pharma Signs MOU to Develop BIOCAD’s mAb Portfolio in China

Life Science

Vivo Capital Closes Latest US-China PE Fund at $635 Million

Life Science

Tencent-backed Meituan raises $4.2 billion in IPO priced near top of range: sources

Technology